University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 12 of 20
Prostate Artery Embolization (PAE) for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT02930889
A Technology-Delivered Peer-to-Peer Support ART Adherence Intervention for Substance-using HIV+ Adults
NCT02704208
Multi-Level Communication Strategies for HPV Vaccination in Hmong Adolescents
NCT04017143
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)
NCT02782442
Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity
NCT02677740
Observational Study of C. Diff in Post-Transplant Patients
NCT02747017
Transcranial Magnetic Stimulation for Facial Pain
NCT02633306
A Study Examining Adolescents With Non-Suicidal Self-Injury
NCT02947308
Iron Deficiency in Female State Fair Attendees
NCT03228173
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
NCT02798679
Effect of Aspirin on Gut Microbiome
NCT02761486
Clinical Intervention in Alcohol Use Disorder
NCT02168400
TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy
NCT02519023
Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients
NCT02099981
The Use of Transcranial Electrical Stimulation for Hallucinations
NCT02715765
Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
NCT02735473
Mobile Application Utilization for Measurement of Scapular Position
NCT02773654
Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
NCT02700048
Interventional Bioremediation of Microbiota in Metabolic Syndrome
NCT02730962
Perinatal Stroke: Understanding Brain Reorganization
NCT02743728
Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
NCT02587351
The Effect of a Low FODMAP Oral Nutrition Supplement On Breath Hydrogen Response In Healthy Human Subjects
NCT02667184
Mindfulness & Stress Management Study for Cardiac Patients
NCT02722213
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
NCT03576365
Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome
NCT02582957
Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)
NCT02829606
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Latino Fathers Promoting Healthy Youth Behaviors
NCT03469752
Vitamin D Levels Following Topical Application of Vitamin D Ointment
NCT02676674
New Ulm at HOME (Healthy Offerings Via the Mealtime Environment), NU-HOME
NCT02973815
Mobile Phone Technology to Increase Genetic Counseling
NCT02877862
Families Preventing Diabetes Together
NCT02721602
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
NCT02685852
Beta-blockers in Pulmonary Arterial Hypertension
NCT02507011
Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia
NCT03346668
A Biomarker to Detect Salt Sensitivity
NCT03147170
Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
NCT02550366
Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain
NCT02630771
Exercise in Multiple Sclerosis
NCT02716701
Synergistic Enteral Regimen for Treatment of the Gangliosidoses
NCT02030015
Differential Sensitivity Markers in Youth Drug Abuse Prevention
NCT02622451
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
NCT02496611
Alveolar Bone Changes in Diabetes (ABCD) Study
NCT02395315
Shoulder Motion Guided Patient Diagnostic and Treatment Classification
NCT02104531
Functional Connectivity In Relation To Proprioception and Sensorimotor Recovery in Stroke Patients (Feasibility Study)
NCT02445768
KAM: Kids Are Moving
NCT02626637
Hormones and Reduction in Co-users of Marijuana and Nicotine
NCT02579421
Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field
NCT02576743
Mitochondrial Dysfunction, Inflammation, and White Matter Integrity in Youth With Mood Disorders
NCT02596698
Predictors of Motor Progression in Parkinson's Disease
NCT02769039
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.